Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline

Carcinogenesis

Volumn 21, Issue 6, 2000, Pages 1213-1219

  Agus, Cynthia ^a,b   Ilett, Kenneth F ^b,d   Kadlubar, Fred F ^c   Minchin, Rodney F ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; DAIDZEIN; GENISTEIN; STAUROSPORINE; TYRPHOSTIN;

ANIMAL TISSUE; ARTICLE; COLON; COVALENT BOND; DNA ADDUCT; DNA BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER; LUNG; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RAT;

EID: 0034047351     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.6.1213     Document Type: Article

References (52)

1. Sugimura, T. (1985) Carcinogenicity of mutagenic heterocyclic amines formed during the cooking process. Mutat. Res., 150, 33-41.
2. Tanaka, T., Barnes, W.S., Williams, G.S. and Weisburger, J.H. (1985) Multipotential Carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Jpn. J. Cancer Res., 76, 570-576.
3. Takayama, S., Nakatsuru, Y., Masuda, M., Ohgaki, H., Sato, S. and Sugimura, T. (1984) Demonstration of Carcinogenicity in F344 rats of 2-amino-3-methylimidazo[4.5-f]quinoline, from broiled sardine, fried beef and beef extract. Jpn. J. Cancer Res., 75, 467-470.
4. Weisburger, J.H., Tanaka, T., Barnes, W.S. and Williams, G.M. (1986) Mutagens and carcinogens formed during cooking. Adv. Exp. Med. Biol., 197, 621-629.
5. Adamson, R.H., Thorgeirsson, U.P., Snyderwine, E.G., Thorgeirsson, S.S., Reeves, J., Dalgard, D.W., Takayama, S. and Sugimura, T. (1990) Carcinogenicity of 2-amino-3-methylimidazo[4.5-f]quinoline in nonhuman primates: induction of tumours in three macaques. Jpn. J. Cancer Res., 81, 10-14.
6. Turesky, R.J., Gremaud, E., Markovic, J. and Snyderwine, E.G. (1996) DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay. Chem. Res. Toxicol., 9, 403-408.
7. Adamson, R.H., Takayama, S., Sugimura, T. and Thorgeirsson, U.P. (1994) Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo[4.5-f]quinoline. Environ. Health Perspect., 102, 190-193.
8. Thorgeirsson, U.P., Farb, A., Virmani, R. and Adamson, R.H. (1994) Cardiac damage induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates. Environ. Health Perspect., 102, 194-199.
9. Adamson, R.H., Farb, A., Virmani, R., Snyderwine, E.G., Thorgeirsson, S.S., Takayama, S., Sugimura, T., Dalgard, D.W. and Thorgeirsson, U.P. (1995) Studies on the carcinogenic and myocardial effects of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in nonhuman primates. Princess Takamatsu Symp., 23, 260-267.
10. Davis, C.D., Farb, A., Thorgeirsson, S.S., Virmani, R. and Synderwine, E.G. (1994) Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. Toxicol. Appl. Pharmacol., 124, 201-211.
11. Felton, J.S., Knize, M.G., Shen, N.H., Andersen, B.D., Bjeldanes, L.F. and Hatch, F.T. (1986) Identification of the mutagens in cooked beef. Environ. Health Perspect., 67, 17-24.
12. Wakabayashi, K., Nagao, M., Esumi, H. and Sugimura, T. (1992) Food-derived mutagens and carcinogens. Cancer Res., 52 (suppl.), 2092s-2098s.
13. Lynch, A.M., Knize, M.G., Boobis, A.R., Gooderham, N.J., Davis, D.S. and Murray, S. (1992) Intra-and inter-individual variability in systemic exposure in man to MelQx and PhIP, carcinogens present in cooked beef. Cancer Res., 52, 6216-6223.
14. 14C]2-amino-1-methyl-6-phenylimidazo[4.5-b]pyridine metabolites in humans. Carcinogenesis, 20, 705-713.
15. McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990) Metabolism of 2-acetylamino-fluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., 50, 3367-3376.
16. Snyderwine, E.G., Wirth, P.J., Roller, P.P., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1988) Mutagenicity and in vitro covalent DNA binding of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline. Carcinogenesis, 9, 411-418.
17. Lin, D.-X., Lang, N.P. and Kadlubar, F.F. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4.5-b]pyridine by hepatic microsomes and cytosols from humans, rats and mice. Drug Metab. Dispos., 23, 518-524.
18. Snyderwine, E.G., Roller, P.P., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1988) Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazo[4,5-f]quinoline with DNA. Synthesis and identification of N-(deoxyguanosin-8-yl)-IQ. Carcinogenesis, 10, 335-341.
19. Wild, D., Dirr, A., Fasshauer, I. and Henschler, D. (1989) Photolysis of arylazides and generation of highly electrophilic DNA-binding and mutagenic intermediates. Carcinogenesis, 12, 1091-1096.
20. Sabbioni, G. and Wild, D. (1992) Quantitative structure-activity relationships of mutagenic aromatic and heteroaromatic azides and amines. Carcinogenesis, 13, 709-713.
21. Schut, H.A.J., Putman, K.L. and Randerath, K. (1988) DNA adduct formation of the carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in target tissues of the F-344 rat. Cancer Lett., 41, 345-352.
22. Turesky, R.J. and Markovic, J. (1995) DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in liver, kidney and colo-rectum of rats. Carcinogenesis, 16, 2275-2279.
23. Davis, C.D., Schut, H.A.J. and Snyderwine, E.G. (1993) Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis, 10, 2091-2096.
24. Snyderwine, E.G., Roller, P.P., Wirth, P.J., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1987) Synthesis, purification and mutagenicity of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline. Carcinogenesis, 8, 1017-1020.
25. Mazel, P. (1971) Experiments illustrating drug metabolism in vitro. In La Du, B.N., Mandel, H.G. and Way, E.L. (eds) Fundementals of Drug Metabolism ami Drug Disposition. Williams and Wilkins, Baltimore, MD, pp. 546-582.
26. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
27. Lin, D.-X., Meyer, D.J., Ketterer, B., Lang, N.P. and Kadlubar, F.F. (1994) Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ-specificity in their carcinogenesis. Cancer Res., 54, 4920-4926.
28. Labarca, C. and Paigen, K. (1980) A simple, rapid and sensitive DNA assay procedure. Anal. Biochem., 102, 344-352.
29. Mulder, G.J., Unruh, L.E., Evans, F.E., Ketterer, B. and Kadlubar, F.F. (1982) Formation and identification of glutathione conjugates from 2-nitrosofluorene and N-hydroxy-2-aminofluorene. Chem. Biol. Interact., 39, 111-127.
30. Djuric, Z., Coles, B., Fifer, E.K., Ketterer, B. and Beland, F.A. (1987) In vivo and in vitro formation of glutathione conjugates from the K-region epoxides of 1-nitropyrene. Carcinogenesis, 8, 1781-1786.
31. Coles, B., Ketterer, B. Beland, F.A. and Kadlubar, F.F. (1984) Glutathione conjugate formation in the detoxification of ultimate and proximate carcinogens of N-methyl-4-aminoazobenzene. Carcinogenesis, 5, 917-920.
32. Felton, J.S., Wu, R., Malfatti, M.A. and Knize, M.G. (1998) Evaluation of the role of acetyl tranferases on heterocyclic amine genotoxicity. In Proceedings of the 1st International Workshop on Arylamine N-acetyltransferases, Cairns, Australia, October.
33. Schwenke, W.D., Soboll, S., Seitz, H.J. and Sies, H. (1981) Mitochondrial and cytosolic ATP/ADP ratios in rat liver in vivo. Biochem. J., 200, 405-408.
34. Reeves, P.T., Minchin, R.F. and Ilett, K.F. (1988) Induction of sulfamethazine acetylation by hydrocortisone in the rabbit. Drug Metab. Dispos., 16, 110-115.
35. Klaassen, C.D. and Boles, J.W. (1997) The importance of 3′-phosphoadenosine 5′-phosphosulfate (PAPS) in the regulation of sulfation. FASEB J., 11, 404-418.
36. Doll, R. and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl Cancer Inst., 66, 1191-1308.
37. Turesky, R.J., Skipper, P.L., Tannenbaum, S.R., Coles, B. and Ketterer, B. (1986) Sulfamate formation is a major route for detoxification of 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Carcinogenesis, 7, 1483-1485.
38. Luks, H.J., Spratt, J.E., Vavrek, M.T., Roland, S.F. and Weisburger, J.H. (1989) Identification of sulfate and glucuronic acid conjugates of the 5-hydroxy derivative as major metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Cancer Res., 49, 4407-4411.
39. Ruiz-Larrea, M.B., Mohan, A.R., Paganga, G., Miller, N.J., Bolwell, G.P. and Rice-Evans, C.A. (1997) Antioxidant activity of phytogenic isoflavones. Free Radic. Res., 26, 63-70.
40. Kanazawa, K., Yamashita, T., Ashida, H. and Danno, G. (1998) Antimutagenicity of flavones and flavonols to heterocyclic amines by specific and strong inhibition of the cytochrome P450 1A family. Biosci. Biotechnol. Biochem., 62, 970-977.
41. Edenharder, R., Rauscher, R. and Platt, K.L. (1997) The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Mutat. Res., 379, 21-32.
42. Hernaez, J., Xu, M. and Dashwood, R. (1997) Effects of tea and chlorophyllin on the mutagenicity of N-hydroxy-IQ: studies of enzyme inhibition, molecular complex formation and degradation/scavenging of the active metabolites. Environ. Mol. Mutagen., 30, 468-474.
43. Weisburger, J.H., Dolan, L. and Pitman, B. (1998) Inhibition of PhIP mutagenicity by caffeine, lycopene, daidzein and genistein. Mutat. Res., 416, 125-128.
44. Edenharder, R., von Petersdorff, I. and Rauscher, R. (1993) Antimutagenic effects of flavonoids, chalcones and structurally related compounds on the activity of 2-amino-3-methylimidazo[4.5-f]quinoline (IQ) and other heterocyclic amine mutagens from cooked food. Mutat. Res., 287, 261-274.
45. Kurzer, M.S. and Xu, X. (1997) Dietary phytoestrogens. Annu. Rev. Nutr., 17, 353-381.
46. Messina, M.J., Persky, V., Setchell, K.D.R. and Barnes, S. (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21, 113-131.
47. Brunskill, N.J., Stuart, J., Tobin, A.B., Walls, J. and Nahorski, S. (1998) Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase. J. Clin. Invest., 101, 2140-2150
48. Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H.J. and Johannes, F.J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isozymes. FEBS Lett., 392, 77-80.
49. Lawrie, A.M., Noble, M.E., Tunnah, P., Brown, N.R., Johnson, L.N. and Endicott, J.A. (1997) Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2. Nature Stuct. Biol., 4, 796-801.
50. Divi, R.L., Chang, H.C. and Doerge, D.R. (1997) Anti-thyroid isoflavones from soybean: isolation, characterization and mechanisms of action. Biochem. Pharmacol., 54, 1087-1096.
51. Gschwendt, M., Muller, H.J., Kielbassa, K., Zang, R., Kittstein, W., Rincke, G. and Marks, F. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun., 199, 93-98.
52. Bilder, G.E., Krawiec, J.A., McVety, K., Gazit, A., Gilon, C., Lyall, R., Zilberstein, A., Levitzki, A., Perrone, M.H. and Schreiber, A.B. (1991) Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells. Am. J. Physiol., 260, C721-C730.